On the other hand, the expression of TGFβ-I in extracellular vesicles isolated from plasma increased similarly after 15 days in MS and MS+OT, but at 30 days, osthole treatment significantly reduced their expression (Figure 6). The gene discussed is TGFBI; the disease is myeloid sarcoma.